Dr. Diane Marie Lis, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 801 Meacham Rd, Elk Grove Village, IL 60007 Phone: 847-584-7090 Fax: 847-584-7092 |
Dr. Shreya N. Patel, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 801 Meacham Rd, Elk Grove Village, IL 60007 Phone: 847-584-7090 |
Elk Grove Optical, P.c. Optometrist Medicare: Medicare Enrolled Practice Location: 611 Meacham Rd, Elk Grove Village, IL 60007 Phone: 847-584-9900 Fax: 847-584-9905 |
Dr. Nisha Jani, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1114 W Devon Ave, Elk Grove Village, IL 60007 Phone: 847-895-7222 Fax: 847-895-0861 |
Village Eye Physicians Optometrist Medicare: Medicare Enrolled Practice Location: 801 Meacham Rd, Elk Grove Village, IL 60007 Phone: 847-584-7090 |
Myeyedr Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1114 W Devon Ave, Elk Grove Village, IL 60007 Phone: 847-895-7222 Fax: 847-895-0861 |
Christina J. Levi O D P C Optometrist Medicare: Not Enrolled in Medicare Practice Location: 611 Meacham Rd, Elk Grove Village, IL 60007 Phone: 847-584-9900 Fax: 314-741-4947 |
Dr. Jesse N Peterman, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1114 W Devon Ave, Elk Grove Village, IL 60007 Phone: 847-895-7222 Fax: 847-895-0861 |
News Archive
The Senate Thursday afternoon passed a health care reform reconciliation bill and sent the bill back to the House for final consideration. The bill passed 56-43.
Recombinant von Willebrand factor (rVWF) may be safe and well tolerated in patients with type 3 and severe type 1 von Willebrand disease, according to interim data from a Phase 1 multicenter, international clinical study presented today at the 52nd Annual Meeting of the American Society of Hematology.
A new study uncovers a gene expression signature that reliably identifies cancer cells whose survival is dependent on a common signaling pathway, even when the cells contain multiple other genetic abnormalities.
Concerns about the use of letrozole, an easy-to-use and inexpensive drug for the treatment of infertility, appear to be unfounded, according to a major study co-authored by Dr. Togas Tulandi, Director of Division of Reproductive Endocrinology and Infertility, McGill University Health Centre (MUHC) and Chief of Obstetrics and Gynecology at the Jewish General Hospital, and Professor of Obstetrics and Gynecology at McGill University.
Researchers at EPFL have built a matchbox-sized device that can test for the presence of bacteria in a couple of minutes, instead of up to several weeks. A nano-lever vibrates in the presence of bacterial activity, while a laser reads the vibration and translates it into an electrical signal that can be easily read-the absence of a signal signifies the absence of bacteria.
› Verified 1 days ago